Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INCY | INCYTE CORP | EVP & Chief Medical Officer | $7.58M | -$1.6M | -17.5% | Apr 1, 2025 |
THRX | Theseus Pharmaceuticals, Inc. | Director | $0 | Feb 14, 2024 | ||
KURA | Kura Oncology, Inc. | Director | Jun 21, 2022 | |||
RPTX | Repare Therapeutics Inc. | Director | Jun 17, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|